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Introduction: Contrast induced nephropathy (CIN) after Percutaneous Coro-
nary Intervention (PCI) for ST segment elevation myocardial infarction
(STEMI) is frequent and associated with mortality and long term renal impaire-
ment. Improving risk stratification of such patients by early markers is needed.
Aim: To assess the association between Nt-proBNP, as an integrated bio-
marker for altered ventricular dysfunction and renal function, and the deve-
lopment of CIN.
Methods: From the (RICO) survey, consecutive patients undergoing a PCI
for a STEMI were included. Patients with cardiogenic shock or severe kidney
disease were excluded. Serum creatinine (Cr) was measured at admission and
48h after PCI. CIN was defined as a rise in Cr >26.5μmol/L or > 50% from
baseline. Nt-proBNP was assessed on admission. 
Results: Among the 1243 patients included, CIN occurred in 130 (10.4%)
patients. Patients who developed CIN had a 5 fold increase in Nt-proBNP
levels when compared with patients without CIN (1275(435-4022) vs 247(79-
986) pg/mL, p<0.001). Hospital mortality was markedly higher in patients with
CIN (6.9% vs 1.1%, p<0.001). Nt-proBNP levels were univariate estimate for CIN
as well as age, hypertension, diabetes, smoking, prior stroke, history of renal insuf-
ficiency, heart rate, altered LVEF, anemia, CRP, and eGFR<30mL/min/1.73m2.
By multivariate analysis, Nt-proBNP levels remains strongly associated with the
occurrence of CIN even after adjustment for risk factors, treatments, clinical, and
biological variables (OR(95%CI): 1.91(1.40-2.60), p<0.001).
Conclusion: From this large contemporary prospective study, our work
suggests that Nt-proBNP levels at admission could help to identify patients at
risk of CIN beyond traditional risk factors. 
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Background: The neutrophil-to-lymphocyte ratio (N/L ratio) reflects the
balance between neutrophil and lymphocyte counts and reflects systemic
inflammatory status.
Aim: We investigated the relationship between the N/L ratio and the myo-
cardial perfusion state assessed by ST-resolution in patients presenting with
ST-elevation myocardial infarction undergoing primary percutaneous coronary
intervention.
Methods: We included patients admitted for STEMI who underwent pri-
mary PCI. Patients were assigned into two groups based on their N/L ratios on
admission. ST resolution was evaluated at 90 minutes after primary PCI in the
worst lead.
Results: 102 consecutive patients were enrolled with a mean age of 56.9±12.7
years. A N/L ratio cut-off of 3.84 defined two groups of 51 patients each. Patients
with low N/L ratio were more likely to have ST segment resolution > 50% than
patients with high N/L ratio (OR = 2.77, CI = 1.11 – 6.93; p = 0.02). Furthermore,
patients with ST resolution < 50% presented higher N/L ratios (4.15±0.61 vs
3.68±0.83; p = 0.002). Multivariate analysis showed that besides blood glucose
level and diabetes, N/L ratio is an independent predictor of ST resolution.
Conclusions: High N/L ratio is a cheap way to predict a poor ST regres-
sion in STEMI patients undergoing primary PCI.
Abstract 0025 – Table: Genetic factor tested in univariate analysis
Genetic 
factors
Cardiovascular 
death
P 
non fatal MI
Composite 
event
Âge à l’inclusion 0,002 0,19 0,012
MTP 0,23 0,09 0,053
XbaI 0,83 0,03 0,1
MspI 0,54 0,25 0,54
PPAR 0,85 1 0,74
Prostacycline synthase 0,43 0,44 0,19
Insertion / 
déléction(ApoB)
0,5 0,75 0,98
Apo CIII 0,05 0,17 0,2
Apo AI 0,77 0,79 0,69
EcoRI 0,27 0,5 0,79
Apo E 0,83 0,17 0,32
LFABP 0,46 0,3 0,85
eCNOS786 0,81 0,63 0,81
eNOS894 0,76 0,3 0,22
eNOS4a4b 0,43 0,05 0,44
MS 0,64 0,64 0,48
CYP1A1 0,88 0,47 0,93
MCP1 0,44 0,48 0,36
leptine 223A/G 0,84 0,085 0,29
leptine 2548G/A 0,43 0,62 0,81
Enzyme de conversion 0,001 0,76 0,38
Bradykinine 0,3 0,24 0,21
CD14 0,64 0,34 0,3
Andino45TG 1 0,03 0,02
rs2781666GT 0,005 0,22 0,39
Apo A51131CT 0,89 0,36 0,72
PON1Q192R 0,16 0,31 0,25
ApoA 51131CT 0,89 0,36 0,72
CBS ins/del 0,68 0,68 0,75
rs2781665AT 0,04 0,77 0,19
CCR2 0,92 0,65 0,81
CBS1080 0,98 0,55 0,57
rs17599586CT 0,63 0,95 0,89
PON2 0,82 0,52 0,43
res420 0,56 0,58 0,7
PPARC161T 0,001 0,4 0,002
rs2781668 0,74 0,76 0,65
TNF863CA 0,81 0,02 0,09
TNF1031TC 0,94 0,71 0,65
PON1L55M 0,6 0,69 0,58
Adiponectine4522CT 0,22 0,32 0,48
TNF308 0,52 0,74 0,56
MTHFRC337 0,38 0,45 0,93
MTHFR1298 0,12 0,12 0,12
MI : Myocardial infarction.
